Toripalimab Injection Clinical Trials
8 recruitingDrug
Phase 26Phase 15Phase 31
Showing 1–8 of 8 trials
Recruiting
Phase 1Phase 2
IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors
Advanced Solid Tumor
Nanjing Immunophage Biotech Co., Ltd52 enrolled1 locationNCT07508761
Recruiting
Phase 1Phase 2
A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma
Advanced Melanoma
Nanjing Leads Biolabs Co.,Ltd200 enrolled15 locationsNCT07099430
Recruiting
Phase 1
Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002
Advanced Solid Tumors
Shanghai Pushi Medical Science Co. Ltd66 enrolled10 locationsNCT06832982
Recruiting
Phase 1Phase 2
A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
Triple-Negative Breast Cancer
Nanjing Leads Biolabs Co.,Ltd220 enrolled7 locationsNCT07281976
Recruiting
Phase 2
9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer
Urothelial Carcinoma
Mabwell (Shanghai) Bioscience Co., Ltd.90 enrolled1 locationNCT07314723
Recruiting
Phase 3
A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.400 enrolled2 locationsNCT07111832
Recruiting
Phase 1Phase 2
A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors
Advanced Solid Tumors
Risen (Suzhou) Pharma Tech Co., Ltd.306 enrolled1 locationNCT06208410
Recruiting
Phase 2
PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer
Stomach Neoplasms
Wan He62 enrolled2 locationsNCT05033392